Skip to main content
# Title Department Research Year
31 Design and synthesis new dihydropyrimidine derivatives with cytotoxic effect as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2024
32 Sustainable and efficient monitoring of tryptophan and tyrosine serum levels: a green HPTLC method as a biomarker for type 2 diabetes Department of Pharmaceutical Analytical Chemistry 2024
33 Design and synthesis of new 1, 2, 4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors Department of Pharmaceutical Organic Chemistry 2024
34 Self‐Calibrating Copper‐Based Metal Organic Frameworks for Ratiometric Electrochemical Sensing of Creatinine Department of Pharmaceutical Analytical Chemistry 2024
35 Evaluating anthelmintic, anti‑platelet, and anti‑coagulant activities, and identifying the bioactive phytochemicals of Amaranthus blitum L. Department of Pharmacognosy 2024
36 Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review Department of Microbiology and Immunology 2024
37 Design, synthesis, and molecular docking of novel 1,3, 4-triaryl pyrazole derivatives bearing methylsulfonyl moiety with anticancer activity through dual targeting CDK2 and COX-2 enzymes Department of Medicinal Chemistry 2024
38 Tetrahydro-(2H)-1,3,5-thiadiazine-2-thione (THTT), A Versatile Carrier System for Targeting Cell Cycle Checkpoint Pathways with Potential Anticancer Activities Department of Medicinal Chemistry 2024
39 Methylene blue-assisted molecularly-imprinted film modified nitrogen and sulfur co-doped molybdenum carbide for simultaneous electrochemical determination of two hepatotoxic drugs Department of Pharmaceutical Analytical Chemistry 2024
40 Highly selective fluorometric detection of streptokinase via fibrinolytic release of photoluminescent carbon dots integrated into fibrin clot network Department of Pharmaceutical Analytical Chemistry 2024